On July 7, 2021, the U.S. Food and Drug Administration (FDA) issued new warnings regarding hydroxyethyl starch (HES) blood volume expanders. Specifically, the FDA is now requiring manufacturers to ...

The basic experimental model tested the ability of an infusion of human plasma to expand the normal plasma volume to a hypervolemic state and to maintain this expansion for several hours. The kinetics ...

When a U.S. soldier is wounded in combat, his lost blood is often replaced with Hextend®, a plasma expander developed by BioTime (www.biotimeinc.com). The high molecular weight plasma expander also is ...

Stem cell technology developer Cell Targeting has sold its assets to BioTime (AMEX:BTX) in a deal worth about $2.3 million. BioTime will pay $250,000 in cash as well as 262,000 shares of BioTime’s ...

Many studies have demonstrated the reality of plasma expanders-induced acidosis and their share of responsibility in metabolic acidosis observed postoperatively after major surgery and in intensive ...

Although donors are compensated for the service and get a free physical, donating plasma has developed a certain stigma that prompted the local plasma center to attempt to dispel misinformation. Drew ...